Pharmacological blockade of TAAR1 with EPPTB significantly attenuates colitis severity by inhibiting trace amine-induced 5-HT signaling, reducing intestinal inflammation, and restoring gut barrier integrity. This evidence concerns the gene TAAR1 and colitis.